The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zhilenkova Yu.I.

Almazov National Medical Research Centre

Chernysh N.Yu.

Almazov National Medical Research Center

Clinical and pathogenetic significance of the determination of serum ferritin in coronavirus disease (COVID-19)

Authors:

Zhilenkova Yu.I., Chernysh N.Yu.

More about the authors

Journal: Laboratory Service. 2021;10(4): 41‑46

DOI: 10.17116/labs20211004141

Read: 5329 times

Download PDF (RU)
Contact the author
Table of contents

CLINICAL AND PATHOGENETIC SIGNIFICANCE OF THE DETERMINATION OF SERUM FERRITIN IN CORONAVIRUS DISEASE (COVID-19)
CLINICAL AND PATHOGENETIC SIGNIFICANCE OF THE DETERMINATION OF SERUM FERRITIN IN CORONAVIRUS DISEASE (COVID-19)

To cite this article:

Zhilenkova YuI, Chernysh NYu. Clinical and pathogenetic significance of the determination of serum ferritin in coronavirus disease (COVID-19). Laboratory Service. 2021;10(4):41‑46. (In Russ.)
https://doi.org/10.17116/labs20211004141

Подписка 2025 Лабораторная служба (Laboratory Service)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
A clinical case of the aortic rupture after SARS-CoV-2 in the patient with Stickler syndrom. Russian Journal of Preventive Medi­cine. 2025;(3):103-106
Post-COVID syndrome: orga­nizing COVID-19-associated pneumonia. Clinical case. Journal of Respiratory Medi­cine. 2025;(1):65-72
Coro­navirus infe­ction as a risk factor in occlusive-stenotic lesions of the brachiocephalic arte­ries. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):44-52
mRNA cancer vaccines: features of problems and collisions. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(1):3-16
SpO2/RR index in choosing the method for correction of acute respiratory failure in COVID-19 patients. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):50-58
Post-Covid aortitis with cardiac invo­lvement: progressive aortic aneurysm combined with active myocarditis. Russian Journal of Archive of Pathology. 2025;(2):53-58
Prediction and prevention of burnout syndrome in health care professionals in high epidemic risk settings. Russian Journal of Preventive Medi­cine. 2025;(4):51-56
Impact of the COVID-19 epidemic on students’ health. Part II. Features of hemo­dynamics, vege­tative regu­lation, resu­lts of psychological and stress resi­stance testing among students depe­nding on the COVID-19 presence in their medi­cal history. Russian Journal of Preventive Medi­cine. 2025;(4):94-101
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Mathematical mode­ling of outcomes in patients with clinical combination of ischemic stroke and COVID-19 complicated by multiple organ failure. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):42-49
Abstract:

For a long time serum ferritin has been known not only as a marker of iron status, but also as a marker of inflammation. However, the pandemic of coronavirus disease forced to look at this laboratory parameter in a new way and widely use it in clinical practice as one of the key marker for assessing the severity of patients with COVID-19. This review presents the results of studies and meta-analyses that show the diagnostic value of serum ferritin as a marker of hyperinflammation, as well as its predictive value in assessing the course and outcomes of COVID-19. Possible mechanisms of its increase in severe disease are considered.

Keywords:

serum ferritin
COVID-19
hyperferritinemic syndromes

Authors:

Zhilenkova Yu.I.

Almazov National Medical Research Centre

Chernysh N.Yu.

Almazov National Medical Research Center

Received:

06.09.2021

Accepted:

27.10.2021

Close metadata

References:

  1. Chen G, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. Journal of Clinical Investigation. 2020;130(5):2620-2629. https://doi.org/10.1172/JCI137244
  2. Qin C, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases. 2020;71(15):762-768.  https://doi.org/10.1093/cid/ciaa248
  3. Li H, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. The Lancet. 2020;395(10235):1517-1520. https://doi.org/10.1016/S0140-6736(20)30920-X
  4. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473-474.  https://doi.org/10.1126/science.abb8925
  5. Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
  6. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: World Health Organization, 2020. https://www.ncbi.nlm.nih.gov/books/NBK569880/
  7. Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401-409.  https://doi.org/10.1093/intimm/dxx031
  8. Lalueza A, et al. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clinical Microbiology and Infection. 2020;26(11):1557.e9-1557.e15.  https://doi.org/10.1016/j.cmi.2020.02.018
  9. Seyhan S, Pamuk ON, Pamuk GE, Cakir N. The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus. Eur J Rheumatol. 2014;1(3):92-95.  https://doi.org/10.5152/eurjrheumatol.2014.032
  10. Ueda N, Takasawa K. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease. Nutrients. 2018;10(9):1173. https://doi.org/10.3390/nu10091173
  11. Van de Veerdonk FL, et al. IL-18 Serum Concentration Is Markedly Elevated in Acute EBV Infection and Can Serve as a Marker for Disease Severity. The Journal of Infectious Diseases. 2012;206(2):197-201.  https://doi.org/10.1093/infdis/jis335
  12. Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y. Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis. Immunology. 2009;128(1pt2):514-522.  https://doi.org/10.1111/j.1365-2567.2008.03021.x
  13. Stylianou E, et al. Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients. Clin Exp Immunol. 2003;132(3):462-466.  https://doi.org/10.1046/j.1365-2249.2003.02179.x
  14. Soundravally R, Agieshkumar B, Daisy M, Sherin J, Cleetus CC. Ferritin levels predict severe dengue. Infection. 2015;43(1):13-19.  https://doi.org/10.1007/s15010-014-0683-4
  15. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM. Ferritin and the response to oxidative stress. Biochemical Journal. 2001;357(1):241-247.  https://doi.org/10.1042/bj3570241
  16. Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: Past, present and future. Biochimica et Biophysica Acta (BBA) — General Subjects. 2010;1800(8):760-769.  https://doi.org/10.1016/j.bbagen.2010.03.011
  17. Ruscitti P, et al. Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations. Sci Rep. 2020;10(1):12232. https://doi.org/10.1038/s41598-020-69031-w
  18. Zhao G, Arosio P, Chasteen ND. Iron(II) and hydrogen peroxide detoxification by human H-chain ferritin. An EPR spin-trapping study. Biochemistry. 2006;45(10):3429-3436. https://doi.org/10.1021/bi052443r
  19. Francisco Veas Acute Phase Proteins — Regulation and Functions of Acute Phase Proteins. 2011. https://www.doabooks.org/doab?func=fulltext&rid=36296
  20. Cohen LA, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood. 2010;116(9):1574-1584. https://doi.org/10.1182/blood-2009-11-253815
  21. Rosário C, Zandman-Goddard G, Meyron-Holtz EG, D’Cruz DP, Shoenfeld Y. The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11(1):185.  https://doi.org/10.1186/1741-7015-11-185
  22. Schulert GS, Grom AA. Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies. Annu Rev Med. 2015;66(1):145-159.  https://doi.org/10.1146/annurev-med-061813-012806
  23. Morris G, et al. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine. 2021;144:155593. https://doi.org/10.1016/j.cyto.2021.155593
  24. Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders. Cytokine & Growth Factor Reviews. 2015;26(3):263-280.  https://doi.org/10.1016/j.cytogfr.2014.10.001
  25. Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. The Lancet. 2014;383(9927):1503-1516. https://doi.org/10.1016/S0140-6736(13)61048-X
  26. Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment. J Pediatr. 2013;163(5):1253-1259. https://doi.org/10.1016/j.jpeds.2013.06.053
  27. Crayne CB, Albeituni S, Nichols KE, Cron RQ. The Immunology of Macrophage Activation Syndrome. Front Immunol. 2019;10:119.  https://doi.org/10.3389/fimmu.2019.00119
  28. McGonagle D, Sharif K, O’Regan A, Bridgewood C. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmunity Reviews. 2020;19(6):102537. https://doi.org/10.1016/j.autrev.2020.102537
  29. Shoenfeld Y. Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmunity Reviews. 2020;19(6):102538. https://doi.org/10.1016/j.autrev.2020.102538
  30. Bai T, et al. Clinical and Laboratory Factors Predicting the Prognosis of Patients with COVID-19: An Analysis of 127 Patients in Wuhan, China. SSRN Journal. 2020. https://doi.org/10.2139/ssrn.3546118
  31. Chen T, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;m1091. https://doi.org/10.1136/bmj.m1091
  32. Liu T, et al. The potential role of IL-6 in monitoring severe case of coronavirus disease 2019. Infectious Diseases (except HIV/AIDS), preprint. 2020. https://doi.org/10.1101/2020.03.01.20029769
  33. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2020;58(7):1021-1028. https://doi.org/10.1515/cclm-2020-0369
  34. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99(10):3505-3516. https://doi.org/10.1182/blood.V99.10.3505
  35. Pretorius E, Kell DB. Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integr Biol. 2014;6(5):486-510.  https://doi.org/10.1039/C4IB00025K
  36. Lipinski B, Pretorius E, Oberholzer HM, Van Der Spuy WJ. Iron enhances generation of fibrin fibers in human blood: Implications for pathogenesis of stroke. Microsc Res Tech. 2012;75(9):1185-1190. https://doi.org/10.1002/jemt.22047
  37. Perricone C, et al. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res. 2020;68(4):213-224.  https://doi.org/10.1007/s12026-020-09145-5
  38. Li X, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology. 2020;146(1):110-118.  https://doi.org/10.1016/j.jaci.2020.04.006
  39. Cheng L, et al. Ferritin in the coronavirus disease 2019 (COVID‐19): A systematic review and meta-analysis. J Clin Lab Anal. 2020;34(10): e23618 . https://doi.org/10.1002/jcla.23618
  40. Gómez-Pastora J, et al. Hyperferritinemia in critically ill COVID-19 patients — Is ferritin the product of inflammation or a pathogenic mediator? Clinica Chimica Acta. 2020;509:249-251.  https://doi.org/10.1016/j.cca.2020.06.033
  41. Dimopoulos G, et al. Favorable Anakinra Responses in Severe COVID-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis. Cell Host & Microbe. 2020;28(1):117-123.  https://doi.org/10.1016/j.chom.2020.05.007
  42. Kyriazopoulou E, et al. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. The Lancet Rheumatology. 2021;S2665991321002162. https://doi.org/10.1016/S2665-9913(21)00216-2
  43. Meng Y, et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol. 2020;13(1):75.  https://doi.org/10.1186/s13045-020-00907-0
  44. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-2040. https://doi.org/10.1182/blood.2020006000
  45. Varga Z, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417-1418. https://doi.org/10.1016/S0140-6736(20)30937-5
  46. Mariappan V, Manoharan PS, Shanmugam PRL, Rao SR, Pillai AB. Potential biomarkers for the early prediction of SARS-CoV-2 disease outcome. Microbial Pathogenesis. 2021;158:105057. https://doi.org/10.1016/j.micpath.2021.105057
  47. https://xn--80aesfpebagmfblc0a.xn--p1ai/ai/doc/872/attach/Bmr_COVID-19_compressed.pdf 
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.